H.R. 10238, titled the "Medical Innovation Act of 2024," allows the U.S. government to collect additional payments from drug manufacturers to boost funding for medical research. This bill targets "blockbuster" drugs, which are those generating over $1 billion in net sales and developed using...
Simple Explanation
The Medical Innovation Act of 2024 is a plan where the U.S. government wants to collect extra money from companies that make really popular and successful medicines. This money will help make sure scientists have enough funds to continue researching and discovering new medical treatments.